INS and metabolic dysfunction-associated steatotic liver disease: Some of the mechanisms shown to be involved in tobacco use and the progression of fibrosis in MASLD include insulin resistance, proinflammatory cytokines, nicotine-activated collagen synthesis, hepatocyte iron accumulation, and activation of stellate cells by oxidative stress [161,163–166].